Cargando…

Durability of response to VGX-3100 treatment of HPV16/18 positive cervical HSIL

VGX-3100 is an investigational DNA-based immunotherapy being developed as an alternative to surgery and ablation for cervical High-Grade Squamous Intraepithelial Lesion (HSIL) with the aim of preserving reproductive health while treating precancerous disease. Response durability up to 1.5 y followin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhuyan, Prakash K., Dallas, Michael, Kraynyak, Kim, Herring, Timothy, Morrow, Matthew, Boyer, Jean, Duff, Susan, Kim, Joseph, Weiner, David B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078703/ https://www.ncbi.nlm.nih.gov/pubmed/33175656 http://dx.doi.org/10.1080/21645515.2020.1823778

Ejemplares similares

Safety and immunogenicity of VGX-3100 formulations in a healthy young adult population
por: Hollenberg, Rebecca K., et al.
Publicado: (2019)

Augmentation of cellular and humoral immune responses to HPV16 and HPV18 E6 and E7 antigens by VGX-3100
por: Morrow, Matthew P, et al.
Publicado: (2016)

Immunotherapy with VGX-3100 (HPV16 and HPV18 plasmids) + INO-9012 (DNA encoding IL-12) in human papillomavirus (HPV) associated head and neck squamous cell carcinoma (HNSCCa): interim safety and immunogenicity results
por: Aggarwal, Charu, et al.
Publicado: (2015)

DNA vaccine VGX-3100 with electroporation induces regression of cervical intraepithelial neoplasia 2/3 and clears HPV infection with robust T cell responses: results of a randomized, double-blind, placebo-controlled Phase II trial
por: Humeau, Laurent, et al.
Publicado: (2014)

Multiple Human Papilloma Virus (HPV) Infections Are Associated with HSIL and Persistent HPV Infection Status in Korean Patients
por: Kim, Moonsik, et al.
Publicado: (2021)

Surgical Treatment of Vulvar HSIL: Adjuvant HPV Vaccine Reduces Recurrent Disease
por: Ghelardi, Alessandro, et al.
Publicado: (2021)

Usefulness of E7 mRNA in HPV16-Positive Women to Predict the Risk of Progression to HSIL/CIN2+
por: Martí, Cristina, et al.
Publicado: (2021)

The value of Ki67 for the diagnosis of LSIL and the problems of p16 in the diagnosis of HSIL
por: Liu, Jixuan, et al.
Publicado: (2022)

Additional role of ECC in the detection and treatment of cervical HSIL
por: Sijing, Li, et al.
Publicado: (2023)

The Diagnostic Utility of p16 Immunostaining in Differentiating Cancer and HSIL from LSIL and Benign in Cervical Cells
por: Wu, Ming-Zhe, et al.
Publicado: (2018)

Is Primary HPV with Secondary p16/Ki67 Dual-Stain an Alternative HSIL-Risk Detection Strategy in Cervical Cancer Screening for Women under 30 Years?
por: Trzeszcz, Martyna, et al.
Publicado: (2021)

Limitations on the Detection Rate of High-Risk HPV by Hybrid Capture 2 Methodology in High Grade Intraepithelial (HSIL) or Atypical Squamous Cells-Cannot Exclude HSIL (ASC-H) Cytological Lesions with Proved CIN2+
por: Noël, Jean-Christophe, et al.
Publicado: (2015)

Effectiveness of the Quadrivalent HPV Vaccine in Preventing Anal ≥ HSILs in a Spanish Population of HIV+ MSM Aged > 26 Years
por: Hidalgo-Tenorio, Carmen, et al.
Publicado: (2021)

Prevalence and risk factors associated with high-grade anal squamous intraepithelial lesions (HSIL)-AIN2 and HSIL-AIN3 in homosexual men
por: Machalek, Dorothy A., et al.
Publicado: (2016)

Immune Therapy Targeting E6/E7 Oncogenes of Human Papillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurrent Respiratory Papillomatosis
por: Aggarwal, Charu, et al.
Publicado: (2020)

COV-VGX: An automated COVID-19 detection system using X-ray images and transfer learning
por: Saha, Prottoy, et al.
Publicado: (2021)

Cytological, Colposcopic and Pathohistological Correlation of HSIL and ASC H Findings
por: Jahic, Mahira, et al.
Publicado: (2020)

Is the U(3100) strange diquonium?
por: Siebert, Hans-Wolfgang
Publicado: (1987)

Role of Low-Risk HPV PCR Monoinfection in Screening for HSIL and Anal Cancer in Men Who Have Sex with Men Living with HIV
por: García-Martínez, Carmen María, et al.
Publicado: (2023)

Is It Time to Genotype Beyond HPV16 and HPV18 for Cervical Cancer Screening?
por: Chua, Brandon Wen Bing, et al.
Publicado: (2022)

Cervical intraepithelial neoplasia 3, coinfected with HPV-16 and -18--case report.
por: Park, J. S., et al.
Publicado: (1993)

Prevalence of HPV 16 and HPV 18 Lineages in Galicia, Spain
por: Pérez, Sonia, et al.
Publicado: (2014)

Effectiveness of AMD3100 in treatment of leukemia and solid tumors: from original discovery to use in current clinical practice
por: Liu, Tao, et al.
Publicado: (2016)

AMD3100/CXCR4 Inhibitor
por: De Clercq, Erik
Publicado: (2015)

Should the management of high grade cervical squamous intraepithelial lesion (HSIL) be different in HIV-positive women?
por: Gilles, Christine, et al.
Publicado: (2021)

Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India
por: Diaz, M, et al.
Publicado: (2008)

The Impact of High-Risk HPV Genotypes Other Than HPV 16/18 on the Natural Course of Abnormal Cervical Cytology: A Korean HPV Cohort Study
por: So, Kyeong A, et al.
Publicado: (2016)

The operation of Luciole on-line to a CDC 3100
por: Blackall, P M, et al.
Publicado: (1966)

Nikon D3100 digital field guide
por: Thomas, J Dennis
Publicado: (2011)

Colposcopic Impression Has a Key Role in the Estimation of the Risk of HSIL/CIN3
por: del Pino, Marta, et al.
Publicado: (2021)

Predictive value of p16(INK4a), Ki-67 and ProExC immuno-qualitative features in LSIL progression into HSIL
por: Ding, Ling, et al.
Publicado: (2020)

Human papillomavirus (HPV) vaccination for the prevention of HPV 16/18 induced cervical cancer and its precursors
por: Damm, Oliver, et al.
Publicado: (2009)

HPV16/18 genotyping for the triage of HPV positive women in primary cervical cancer screening in Chile
por: Lagos, Marcela, et al.
Publicado: (2015)

Prevalence of HPV 16 and 18 and attitudes toward HPV vaccination trials in patients with cervical cancer in Mali
por: Téguété, Ibrahima, et al.
Publicado: (2017)

The correlation of HPV16 and HPV18 with local vaginal immunity after the treatment of cervical intraepithelial neoplasia
por: Mu, Lin, et al.
Publicado: (2020)

HPV16 and HPV18 Genome Structure, Expression, and Post-Transcriptional Regulation
por: Yu, Lulu, et al.
Publicado: (2022)

[(18)F]DPA-714 PET Imaging of AMD3100 Treatment in a Mouse Model of Stroke
por: Wang, Yu, et al.
Publicado: (2014)

Absence of HPV 16 and 18 DNA in breast cancer.
por: Wrede, D., et al.
Publicado: (1992)

Monitoring HPV16/18 immunisation in England and elsewhere
por: Franceschi, S
Publicado: (2010)

Triage of HPV-positive women in Norway using cytology, HPV16/18 genotyping and HPV persistence
por: Arbyn, Marc, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pfl1l1s359ke3ucepdfdtf2dg0